世界のソマトスタチン及びソマトスタチン類似体市場:成長動向・競争分析2020-2026

【英語タイトル】Global Somatostatin and Somatostatin Analogs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP02255)・商品コード:QYR20AP02255
・発行会社(調査会社):QYResearch
・発行日:2020年3月23日(※2024年版があります。お問い合わせください)
・ページ数:117
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、ソマトスタチン及びソマトスタチン類似体の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ソマトスタチン及びソマトスタチン類似体のグローバル市場動向、メーカー別競争状況、種類別市場規模(オクトレオチド、ランレオチド、パシレオチド、その他)、用途別市場規模(病院、薬局、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ソマトスタチン及びソマトスタチン類似体の種類別市場2015-2026:オクトレオチド、ランレオチド、パシレオチド、その他
・ソマトスタチン及びソマトスタチン類似体の用途別市場2015-2026:病院、薬局、その他
・ソマトスタチン及びソマトスタチン類似体の北米市場分析
・ソマトスタチン及びソマトスタチン類似体のアジア市場分析
・ソマトスタチン及びソマトスタチン類似体の中南米市場分析
・ソマトスタチン及びソマトスタチン類似体の中東・アフリカ市場分析
・関連企業情報:Novartis、Pfizer、Ispen、HYBIO、TianTaiShan
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.In 2019, the global Somatostatin and Somatostatin Analogs market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Somatostatin and Somatostatin Analogs.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Somatostatin and Somatostatin Analogs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Somatostatin and Somatostatin Analogs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Somatostatin and Somatostatin Analogs market. Readers of the report can become informed about current and future trends of the global Somatostatin and Somatostatin Analogs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Somatostatin and Somatostatin Analogs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Somatostatin and Somatostatin Analogs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Somatostatin and Somatostatin Analogs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Somatostatin and Somatostatin Analogs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Somatostatin and Somatostatin Analogs market is segmented into
Octreotide
Lanreotide
Pasireotide
Other

Market Segment by Application, the Somatostatin and Somatostatin Analogs market is segmented into
Hospital
Pharmacy
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Novartis
Pfizer
Ispen
HYBIO
TianTaiShan

The study objectives are:
To analyze and research the global Somatostatin and Somatostatin Analogs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Somatostatin and Somatostatin Analogs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Somatostatin and Somatostatin Analogs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Somatostatin and Somatostatin Analogs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Somatostatin and Somatostatin Analogs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Octreotide
1.3.3 Lanreotide
1.3.4 Pasireotide
1.3.5 Other
1.4 Market Segment by Application
1.4.1 Global Somatostatin and Somatostatin Analogs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Somatostatin and Somatostatin Analogs Revenue (2015-2026)
2.1.1 Global Somatostatin and Somatostatin Analogs Revenue (2015-2026)
2.1.2 Global Somatostatin and Somatostatin Analogs Sales (2015-2026)
2.2 Somatostatin and Somatostatin Analogs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Somatostatin and Somatostatin Analogs Sales by Regions (2015-2020)
2.2.2 Global Somatostatin and Somatostatin Analogs Revenue by Regions (2015-2020)
2.3 Global Top Somatostatin and Somatostatin Analogs Regions (Countries) Ranking by Market Size
2.4 Somatostatin and Somatostatin Analogs Industry Trends
2.4.1 Somatostatin and Somatostatin Analogs Market Top Trends
2.4.2 Market Drivers
2.4.3 Somatostatin and Somatostatin Analogs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Somatostatin and Somatostatin Analogs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Somatostatin and Somatostatin Analogs Manufacturers by Sales (2015-2020)
3.1.1 Global Somatostatin and Somatostatin Analogs Sales by Manufacturers (2015-2020)
3.1.2 Global Somatostatin and Somatostatin Analogs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Somatostatin and Somatostatin Analogs Sales in 2019
3.2 Global Top Manufacturers Somatostatin and Somatostatin Analogs by Revenue
3.2.1 Global Somatostatin and Somatostatin Analogs Revenue by Manufacturers (2015-2020)
3.2.2 Global Somatostatin and Somatostatin Analogs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Somatostatin and Somatostatin Analogs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin and Somatostatin Analogs as of 2019)
3.4 Global Somatostatin and Somatostatin Analogs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Somatostatin and Somatostatin Analogs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Somatostatin and Somatostatin Analogs Market
3.7 Key Manufacturers Somatostatin and Somatostatin Analogs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Somatostatin and Somatostatin Analogs Historic Market Review by Type (2015-2020)
4.1.2 Global Somatostatin and Somatostatin Analogs Sales Market Share by Type (2015-2020)
4.1.3 Global Somatostatin and Somatostatin Analogs Revenue Market Share by Type (2015-2020)
4.1.4 Somatostatin and Somatostatin Analogs Price by Type (2015-2020)
4.1 Global Somatostatin and Somatostatin Analogs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Somatostatin and Somatostatin Analogs Sales Forecast by Type (2021-2026)
4.2.3 Global Somatostatin and Somatostatin Analogs Revenue Forecast by Type (2021-2026)
4.2.4 Somatostatin and Somatostatin Analogs Price Forecast by Type (2021-2026)

5 Global Somatostatin and Somatostatin Analogs Market Size by Application
5.1 Global Somatostatin and Somatostatin Analogs Historic Market Review by Application (2015-2020)
5.1.2 Global Somatostatin and Somatostatin Analogs Sales Market Share by Application (2015-2020)
5.1.3 Global Somatostatin and Somatostatin Analogs Revenue Market Share by Application (2015-2020)
5.1.4 Somatostatin and Somatostatin Analogs Price by Application (2015-2020)
5.2 Global Somatostatin and Somatostatin Analogs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Somatostatin and Somatostatin Analogs Sales Forecast by Application (2021-2026)
5.2.3 Global Somatostatin and Somatostatin Analogs Revenue Forecast by Application (2021-2026)
5.2.4 Somatostatin and Somatostatin Analogs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Somatostatin and Somatostatin Analogs Breakdown Data by Company
6.2 North America Somatostatin and Somatostatin Analogs Breakdown Data by Type
6.3 North America Somatostatin and Somatostatin Analogs Breakdown Data by Application
6.4 North America Somatostatin and Somatostatin Analogs Breakdown Data by Countries
6.4.1 North America Somatostatin and Somatostatin Analogs Sales by Countries
6.4.2 North America Somatostatin and Somatostatin Analogs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Somatostatin and Somatostatin Analogs Breakdown Data by Company
7.2 Europe Somatostatin and Somatostatin Analogs Breakdown Data by Type
7.3 Europe Somatostatin and Somatostatin Analogs Breakdown Data by Application
7.4 Europe Somatostatin and Somatostatin Analogs Breakdown Data by Countries
7.4.1 Europe Somatostatin and Somatostatin Analogs Sales by Countries
7.4.2 Europe Somatostatin and Somatostatin Analogs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Somatostatin and Somatostatin Analogs Breakdown Data by Company
8.2 Asia Pacific Somatostatin and Somatostatin Analogs Breakdown Data by Type
8.3 Asia Pacific Somatostatin and Somatostatin Analogs Breakdown Data by Application
8.4 Asia Pacific Somatostatin and Somatostatin Analogs Breakdown Data by Regions
8.4.1 Asia Pacific Somatostatin and Somatostatin Analogs Sales by Regions
8.4.2 Asia Pacific Somatostatin and Somatostatin Analogs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Somatostatin and Somatostatin Analogs Breakdown Data by Company
9.2 Latin America Somatostatin and Somatostatin Analogs Breakdown Data by Type
9.3 Latin America Somatostatin and Somatostatin Analogs Breakdown Data by Application
9.4 Latin America Somatostatin and Somatostatin Analogs Breakdown Data by Countries
9.4.1 Latin America Somatostatin and Somatostatin Analogs Sales by Countries
9.4.2 Latin America Somatostatin and Somatostatin Analogs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Somatostatin and Somatostatin Analogs Breakdown Data by Type
10.2 Middle East and Africa Somatostatin and Somatostatin Analogs Breakdown Data by Application
10.3 Middle East and Africa Somatostatin and Somatostatin Analogs Breakdown Data by Countries
10.3.1 Middle East and Africa Somatostatin and Somatostatin Analogs Sales by Countries
10.3.2 Middle East and Africa Somatostatin and Somatostatin Analogs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Novartis Somatostatin and Somatostatin Analogs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Novartis Somatostatin and Somatostatin Analogs Products and Services
11.1.5 Novartis SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Pfizer Somatostatin and Somatostatin Analogs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Pfizer Somatostatin and Somatostatin Analogs Products and Services
11.2.5 Pfizer SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Ispen
11.3.1 Ispen Corporation Information
11.3.2 Ispen Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Ispen Somatostatin and Somatostatin Analogs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Ispen Somatostatin and Somatostatin Analogs Products and Services
11.3.5 Ispen SWOT Analysis
11.3.6 Ispen Recent Developments
11.4 HYBIO
11.4.1 HYBIO Corporation Information
11.4.2 HYBIO Business Overview and Total Revenue (2019 VS 2018)
11.4.3 HYBIO Somatostatin and Somatostatin Analogs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 HYBIO Somatostatin and Somatostatin Analogs Products and Services
11.4.5 HYBIO SWOT Analysis
11.4.6 HYBIO Recent Developments
11.5 TianTaiShan
11.5.1 TianTaiShan Corporation Information
11.5.2 TianTaiShan Business Overview and Total Revenue (2019 VS 2018)
11.5.3 TianTaiShan Somatostatin and Somatostatin Analogs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 TianTaiShan Somatostatin and Somatostatin Analogs Products and Services
11.5.5 TianTaiShan SWOT Analysis
11.5.6 TianTaiShan Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Somatostatin and Somatostatin Analogs Sales Channels
12.2.2 Somatostatin and Somatostatin Analogs Distributors
12.3 Somatostatin and Somatostatin Analogs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Somatostatin and Somatostatin Analogs Sales Forecast (2021-2026)
13.1.1 Global Somatostatin and Somatostatin Analogs Sales Forecast by Regions (2021-2026)
13.1.2 Global Somatostatin and Somatostatin Analogs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Somatostatin and Somatostatin Analogs Sales Forecast (2021-2026)
13.2.2 North America Somatostatin and Somatostatin Analogs Revenue Forecast (2021-2026)
13.2.3 North America Somatostatin and Somatostatin Analogs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Somatostatin and Somatostatin Analogs Sales Forecast (2021-2026)
13.3.2 Europe Somatostatin and Somatostatin Analogs Revenue Forecast (2021-2026)
13.3.3 Europe Somatostatin and Somatostatin Analogs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Somatostatin and Somatostatin Analogs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Somatostatin and Somatostatin Analogs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Somatostatin and Somatostatin Analogs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Somatostatin and Somatostatin Analogs Sales Forecast (2021-2026)
13.5.2 Latin America Somatostatin and Somatostatin Analogs Revenue Forecast (2021-2026)
13.5.3 Latin America Somatostatin and Somatostatin Analogs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Somatostatin and Somatostatin Analogs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Somatostatin and Somatostatin Analogs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Somatostatin and Somatostatin Analogs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Somatostatin and Somatostatin Analogs Key Market Segments
Table 2. Ranking of Global Top Somatostatin and Somatostatin Analogs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Somatostatin and Somatostatin Analogs Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Octreotide
Table 5. Major Manufacturers of Lanreotide
Table 6. Major Manufacturers of Pasireotide
Table 7. Major Manufacturers of Other
Table 8. Global Somatostatin and Somatostatin Analogs Market Share by Application 2019-2025 (K Units)
Table 9. Global Somatostatin and Somatostatin Analogs Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 10. Global Somatostatin and Somatostatin Analogs Sales by Regions 2015-2020 (K Units)
Table 11. Global Somatostatin and Somatostatin Analogs Sales Market Share by Regions 2015-2020
Table 12. Global Somatostatin and Somatostatin Analogs Revenue by Regions 2015-2020 (Million US$)
Table 13. Global Somatostatin and Somatostatin Analogs Revenue Market Share by Regions 2015-2020
Table 14. Top Somatostatin and Somatostatin Analogs Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 15. Market Top Trends
Table 16. Somatostatin and Somatostatin Analogs Key Drivers: Impact Analysis (2021-2026)
Table 17. Somatostatin and Somatostatin Analogs Key Challenges
Table 18. Main Points Interviewed from Key Somatostatin and Somatostatin Analogs Players: Views for Future
Table 19. Global Somatostatin and Somatostatin Analogs Sales by Manufacturers (2015-2020) (K Units)
Table 20. Global Somatostatin and Somatostatin Analogs Sales Share by Manufacturers (2015-2020)
Table 21. Somatostatin and Somatostatin Analogs Revenue by Manufacturers (2015-2020) (Million US$)
Table 22. Somatostatin and Somatostatin Analogs Revenue Share by Manufacturers (2015-2020)
Table 23. Global Somatostatin and Somatostatin Analogs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin and Somatostatin Analogs as of 2019)
Table 25. Key Manufacturers Somatostatin and Somatostatin Analogs Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 26. Key Manufacturers Somatostatin and Somatostatin Analogs Plants/Factories Distribution
Table 27. Key Manufacturers Somatostatin and Somatostatin Analogs Area Served
Table 28. Date of Key Manufacturers Enter into Somatostatin and Somatostatin Analogs Market
Table 29. Key Manufacturers Somatostatin and Somatostatin Analogs Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Octreotide Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 32. Global Lanreotide Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 33. Global Pasireotide Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 34. Global Other Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 35. Global Somatostatin and Somatostatin Analogs Sales (K Units) by Type (2015-2020)
Table 36. Global Somatostatin and Somatostatin Analogs Sales Share by Type (2015-2020)
Table 37. Global Somatostatin and Somatostatin Analogs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 38. Global Somatostatin and Somatostatin Analogs Price (K Units) by Type (2015-2020)
Table 39. Global Somatostatin and Somatostatin Analogs Sales (K Units) by Type (2021-2026)
Table 40. Global Somatostatin and Somatostatin Analogs Sales Share by Type (2021-2026)
Table 41. Global Somatostatin and Somatostatin Analogs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 42. Global Somatostatin and Somatostatin Analogs Revenue Share by Type (2021-2026)
Table 43. Global Somatostatin and Somatostatin Analogs Price (K Units) by Type (2021-2026)
Table 44. Global Somatostatin and Somatostatin Analogs Sales (K Units) by Application (2015-2020)
Table 45. Global Somatostatin and Somatostatin Analogs Sales Share by Application (2015-2020)
Table 46. Global Somatostatin and Somatostatin Analogs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 47. Global Somatostatin and Somatostatin Analogs Price by Application 2015-2020 (USD/Unit)
Table 48. Global Somatostatin and Somatostatin Analogs Sales by Application (2015-2020) (K Units)
Table 49. Global Somatostatin and Somatostatin Analogs Sales Share by Application (2015-2020)
Table 50. Global Somatostatin and Somatostatin Analogs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 51. Global Somatostatin and Somatostatin Analogs Revenue Share by Application (2021-2026)
Table 52. Global Somatostatin and Somatostatin Analogs Price (K Units) by Application (2021-2026)
Table 53. North America Somatostatin and Somatostatin Analogs Sales by Company (2015-2020) (K Units)
Table 54. North America Somatostatin and Somatostatin Analogs Sales Market Share by Company (2015-2020)
Table 55. North America Somatostatin and Somatostatin Analogs Sales by Type (2015-2020) (K Units)
Table 56. North America Somatostatin and Somatostatin Analogs Sales Market Share by Type (2015-2020)
Table 57. North America Somatostatin and Somatostatin Analogs Sales by Application (2015-2020) (K Units)
Table 58. North America Somatostatin and Somatostatin Analogs Sales Market Share by Application (2015-2020)
Table 59. North America Somatostatin and Somatostatin Analogs Sales by Countries (2015-2020) (K Units)
Table 60. North America Somatostatin and Somatostatin Analogs Sales Market Share by Countries (2015-2020)
Table 61. North America Somatostatin and Somatostatin Analogs Revenue by Countries (2015-2020) (Million US$)
Table 62. North America Somatostatin and Somatostatin Analogs Revenue Market Share by Countries (2015-2020)
Table 63. Europe Somatostatin and Somatostatin Analogs Sales by Company (2015-2020) (K Units)
Table 64. Europe Somatostatin and Somatostatin Analogs Sales Market Share by Company (2015-2020)
Table 65. Europe Somatostatin and Somatostatin Analogs Sales by Type (2015-2020) (K Units)
Table 66. Europe Somatostatin and Somatostatin Analogs Sales Market Share by Type (2015-2020)
Table 67. Europe Somatostatin and Somatostatin Analogs Sales by Application (2015-2020) (K Units)
Table 68. Europe Somatostatin and Somatostatin Analogs Sales Market Share by Application (2015-2020)
Table 69. Europe Somatostatin and Somatostatin Analogs Sales by Countries (2015-2020) (K Units)
Table 70. Europe Somatostatin and Somatostatin Analogs Sales Market Share by Countries (2015-2020)
Table 71. Europe Somatostatin and Somatostatin Analogs Revenue by Countries (2015-2020) (Million US$)
Table 72. Europe Somatostatin and Somatostatin Analogs Revenue Market Share by Countries (2015-2020)
Table 73. Asia Pacific Somatostatin and Somatostatin Analogs Sales by Regions (2015-2020) (K Units)
Table 74. Asia Pacific Somatostatin and Somatostatin Analogs Sales Market Share by Regions (2015-2020)
Table 75. Asia Pacific Somatostatin and Somatostatin Analogs Sales by Type (2015-2020) (K Units)
Table 76. Asia Pacific Somatostatin and Somatostatin Analogs Sales Market Share by Type (2015-2020)
Table 77. Asia Pacific Somatostatin and Somatostatin Analogs Sales by Application (2015-2020) (K Units)
Table 78. Asia Pacific Somatostatin and Somatostatin Analogs Sales Market Share by Application (2015-2020)
Table 79. Asia Pacific Somatostatin and Somatostatin Analogs Sales by Countries (2015-2020) (K Units)
Table 80. Asia Pacific Somatostatin and Somatostatin Analogs Sales Market Share by Regions (2015-2020)
Table 81. Asia Pacific Somatostatin and Somatostatin Analogs Revenue by Regions (2015-2020) (Million US$)
Table 82. Asia Pacific Somatostatin and Somatostatin Analogs Revenue Market Share by Regions (2015-2020)
Table 83. Latin America Somatostatin and Somatostatin Analogs Sales by Company (2015-2020) (K Units)
Table 84. Latin America Somatostatin and Somatostatin Analogs Sales Market Share by Company (2015-2020)
Table 85. Latin America Somatostatin and Somatostatin Analogs Sales by Type (2015-2020) (K Units)
Table 86. Latin America Somatostatin and Somatostatin Analogs Sales Market Share by Type (2015-2020)
Table 87. Latin America Somatostatin and Somatostatin Analogs Sales by Application (2015-2020) (K Units)
Table 88. Latin America Somatostatin and Somatostatin Analogs Sales Market Share by Application (2015-2020)
Table 89. Latin America Somatostatin and Somatostatin Analogs Sales by Countries (2015-2020) (K Units)
Table 90. Latin America Somatostatin and Somatostatin Analogs Sales Market Share by Countries (2015-2020)
Table 91. Latin America Somatostatin and Somatostatin Analogs Revenue by Countries (2015-2020) (Million US$)
Table 92. Latin America Somatostatin and Somatostatin Analogs Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Somatostatin and Somatostatin Analogs Sales by Type (2015-2020) (K Units)
Table 94. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Market Share by Type (2015-2020)
Table 95. Middle East and Africa Somatostatin and Somatostatin Analogs Sales by Application (2015-2020) (K Units)
Table 96. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Market Share by Application (2015-2020)
Table 97. Middle East and Africa Somatostatin and Somatostatin Analogs Sales by Countries (2015-2020) (K Units)
Table 98. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Somatostatin and Somatostatin Analogs Revenue by Countries (2015-2020) (Million US$)
Table 100. Middle East and Africa Somatostatin and Somatostatin Analogs Revenue Market Share by Countries (2015-2020)
Table 101. Novartis Company Details
Table 102. Novartis Description and Business Overview
Table 103. Novartis Somatostatin and Somatostatin Analogs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Novartis Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020)
Table 105. Novartis Somatostatin and Somatostatin Analogs Sales Market Share in Global Market
Table 106. Novartis Recent Development
Table 107. Pfizer Company Details
Table 108. Pfizer Description and Business Overview
Table 109. Pfizer Somatostatin and Somatostatin Analogs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Pfizer Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020)
Table 111. Pfizer Somatostatin and Somatostatin Analogs Sales Market Share in Global Market
Table 112. Pfizer Recent Development
Table 113. Ispen Company Details
Table 114. Ispen Description and Business Overview
Table 115. Ispen Somatostatin and Somatostatin Analogs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Ispen Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020)
Table 117. Ispen Somatostatin and Somatostatin Analogs Sales Market Share in Global Market
Table 118. Ispen Recent Development
Table 119. HYBIO Company Details
Table 120. HYBIO Description and Business Overview
Table 121. HYBIO Somatostatin and Somatostatin Analogs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. HYBIO Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020)
Table 123. HYBIO Somatostatin and Somatostatin Analogs Sales Market Share in Global Market
Table 124. HYBIO Recent Development
Table 125. TianTaiShan Company Details
Table 126. TianTaiShan Description and Business Overview
Table 127. TianTaiShan Somatostatin and Somatostatin Analogs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. TianTaiShan Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020)
Table 129. TianTaiShan Somatostatin and Somatostatin Analogs Sales Market Share in Global Market
Table 130. TianTaiShan Recent Development
Table 131. Somatostatin and Somatostatin Analogs Distributors List
Table 132. Somatostatin and Somatostatin Analogs Customers List
Table 133. Global Somatostatin and Somatostatin Analogs Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 134. Global Somatostatin and Somatostatin Analogs Sales Forecast by Type 2021-2026 (K Units)
Table 135. Global Somatostatin and Somatostatin Analogs Sales Forecast by Application 2021-2026 (K Units)
Table 136. Global Somatostatin and Somatostatin Analogs Sales Forecast by Regions 2021-2026 (K Units)
Table 137. Global Somatostatin and Somatostatin Analogs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 138. North America Somatostatin and Somatostatin Analogs Sales Forecast by Countries 2021-2026 (K Units)
Table 139. North America Somatostatin and Somatostatin Analogs Revenue Forecast by Countries 2021-2026
Table 140. Europe Somatostatin and Somatostatin Analogs Sales Forecast by Countries 2021-2026 (K Units)
Table 141. Europe Somatostatin and Somatostatin Analogs Revenue Market Share Forecast by Countries 2021-2026
Table 142. Asia Pacific Somatostatin and Somatostatin Analogs Sales Forecast by Regions 2021-2026 (K Units)
Table 143. Asia Pacific Somatostatin and Somatostatin Analogs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 144. Latin America Somatostatin and Somatostatin Analogs Sales Forecast by Countries 2021-2026 (K Units)
Table 145. Latin America Somatostatin and Somatostatin Analogs Revenue Forecast by Countries 2021-2026 (Million US$)
Table 146. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Forecast by Regions 2021-2026 (K Units)
Table 147. Middle East and Africa Somatostatin and Somatostatin Analogs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Somatostatin and Somatostatin Analogs Product Picture
Figure 2. Global Somatostatin and Somatostatin Analogs Sales Market Shar by Type 2015-2026
Figure 3. Octreotide Figures
Figure 4. Lanreotide Figures
Figure 5. Pasireotide Figures
Figure 6. Other Figures
Figure 7. Global Somatostatin and Somatostatin Analogs Sales Market Share by Application in 2019 & 2026
Figure 8. Hospital Use Case
Figure 9. Pharmacy Use Case
Figure 10. Other Use Case
Figure 11. Somatostatin and Somatostatin Analogs Report Years Considered
Figure 12. Global Somatostatin and Somatostatin Analogs Market Size 2015-2026 (Million US$)
Figure 13. Global Somatostatin and Somatostatin Analogs Sales 2015-2020 (K Units)
Figure 14. Global Somatostatin and Somatostatin Analogs Market Size Market Share by Regions 2015-2020
Figure 15. Global Somatostatin and Somatostatin Analogs Sales Market Share by Regions in 2019
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Somatostatin and Somatostatin Analogs Sales Share by Manufacturers in 2019
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Somatostatin and Somatostatin Analogs Sales in 2019
Figure 19. Somatostatin and Somatostatin Analogs Value Share by Manufacturers in 2019
Figure 20. Somatostatin and Somatostatin Analogs Revenue Share by Manufacturers In 2019
Figure 21. Somatostatin and Somatostatin Analogs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Somatostatin and Somatostatin Analogs Revenue Share by Type (2015-2020)
Figure 23. Global Somatostatin and Somatostatin Analogs Revenue Growth Rate by Type in 2015 & 2019
Figure 24. Global Somatostatin and Somatostatin Analogs Market Share by Price Range (2015-2020)
Figure 25. Global Somatostatin and Somatostatin Analogs Revenue Share by Application (2015-2020)
Figure 26. Global Somatostatin and Somatostatin Analogs Revenue Growth Rate by Application in 2015 & 2019
Figure 27. North America Somatostatin and Somatostatin Analogs Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. U.S. Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 29. Canada Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 30. Europe Somatostatin and Somatostatin Analogs Revenue Growth Rate 2015-2020 (Million US$)
Figure 31. Germany Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Russia Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Asia Pacific Somatostatin and Somatostatin Analogs Revenue Growth Rate 2015-2020 (Million US$)
Figure 37. China Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Japan Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 39. South Korea Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 40. India Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Australia Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 42. Taiwan Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Indonesia Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Thailand Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Malaysia Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Philippines Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Vietnam Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Latin America Somatostatin and Somatostatin Analogs Revenue Growth Rate 2015-2020 (Million US$)
Figure 49. Mexico Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Brazil Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Argentina Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Middle East and Africa Somatostatin and Somatostatin Analogs Revenue Growth Rate 2015-2020 (Million US$)
Figure 53. Turkey Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Saudi Arabia Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.A.E Somatostatin and Somatostatin Analogs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Ispen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. HYBIO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. TianTaiShan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Somatostatin and Somatostatin Analogs Value Chain
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. North America Somatostatin and Somatostatin Analogs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 65. North America Somatostatin and Somatostatin Analogs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 66. Europe Somatostatin and Somatostatin Analogs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 67. Europe Somatostatin and Somatostatin Analogs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Asia Pacific Somatostatin and Somatostatin Analogs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 69. Asia Pacific Somatostatin and Somatostatin Analogs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Latin America Somatostatin and Somatostatin Analogs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 71. Latin America Somatostatin and Somatostatin Analogs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Middle East and Africa Somatostatin and Somatostatin Analogs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 73. Middle East and Africa Somatostatin and Somatostatin Analogs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed


【掲載企業】

Novartis、Pfizer、Ispen、HYBIO、TianTaiShan

★調査レポート[世界のソマトスタチン及びソマトスタチン類似体市場:成長動向・競争分析2020-2026] (コード:QYR20AP02255)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のソマトスタチン及びソマトスタチン類似体市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆